Cefminox sodium compound reducing adverse reactions and preparation thereof
The invention relates to an antibiotic drug, in particular to a preparation process of cefminox sodium compound reducing adverse reactions and a preparation of the cefminox sodium compound. The preparation process has the advantages such as high yield and high purity and is suitable for industrial production, and an obtained product has significant improvements in terms of product stability, preparations to reduce adverse reactions, and clinical application.
-
Paragraph 0033; 0035
(2017/01/02)
More Articles about upstream products of 75498-96-3
Get Best Price for75498-96-3(6r-(6-alpha,7-alpha))-7-((((2-amino-2-carboxyethyl)thio)acetyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid monosodium salt
